Overview

Shifting Pain Modulation From Pro-to Anti-nociceptive

Status:
Terminated
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
To create a data base that will facilitate the enrichment of the insights regarding post-operative pain development, and to identify those individuals with the potential to develop this kind of pain. The identification will be based on the individualized pain modulation profile, composed of a battery of tests as detailed below.
Phase:
N/A
Details
Lead Sponsor:
Rambam Health Care Campus
Treatments:
Duloxetine Hydrochloride
Pregabalin